The effect of the IL-33/ST2 pathway on immune diseases is closely related to susceptibility to autoimmune thyroid disease and some genetic variants of IL-33/ST2 and its related neighboring genes, which provides new ideas for existing therapeutic approaches in the future. This evidence concerns the gene IL1RL1 and autoimmune thyroid disease.